Neuronetics (STIM) Stock Analysis
NASDAQHealthcareMedical - Devices
What Neuronetics does
Neuronetics, Inc. functions as a medical technology enterprise with commercialized products, specializing in the creation, enhancement, and global distribution of solutions for individuals experiencing neurohealth conditions, both within the U.S. and abroad. The company's flagship product is the NeuroStar Advanced Therapy System, an in-office, non-surgical, and non-pharmaceutical treatment option available for adult patients diagnosed with major depressive disorder. This sophisticated system utilizes transcranial magnetic stimulation (TMS) to generate a pulsed magnetic field, similar in strength to an MRI, which subsequently induces electrical currents. These currents are specifically engineered to activate brain areas that are key to mood regulation. Neuronetics distributes its offerings directly to psychiatrists through its dedicated sales and client support personnel. Established in 2001, the company's corporate headquarters are situated in Malvern, Pennsylvania.
Key metrics
ETFs linked to STIM
Broad-market and Healthcare sector ETFs an investor holding Neuronetics is often also exposed to. Open an ETF page to see its actual top holdings.
PortView Portfolio Insights
PortView analyzes how STIM fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.
Analyze STIM in PortView →Similar companies
Frequently asked questions
- What is the ticker symbol for Neuronetics?
- Neuronetics trades under the ticker STIM on NASDAQ.
- Which exchange is STIM listed on?
- STIM is listed on NASDAQ.
- What sector does Neuronetics operate in?
- Neuronetics is classified in the Healthcare sector (Medical - Devices industry).
- How can PortView help analyze STIM in a portfolio?
- PortView shows STIM's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.
The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.